camptothecin has been researched along with cyclin d1 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bargonetti, J; Chen, X; Prives, C | 1 |
| Geller, HM; Greene, LA; Morris, EJ; Padmanabhan, J; Park, DS; Shelanski, ML | 1 |
| Bremner, R; Geller, HM; Greene, LA; Keramaris, E; Morris, EJ; Padmanabhan, J; Park, DS; Rosenbaum, M; Shelanski, ML | 1 |
| Evans, JF; Kargman, S; Kelly, CR; Kwong, E; Lam, EC; Luk, P; Wolfe, MM; Yao, M; Zheng, Y | 1 |
| Laurent-Puig, P; Lièvre, A | 1 |
| Ducreux, M; Laurent-Puig, P; Lièvre, A; Loriot, MA | 1 |
| Bayani, N; Bhattacharya, S; Bissell, MJ; Das, D; Feiler, HS; Gascard, P; Gendelman, R; Gray, JW; Guan, Y; Heiser, LM; Hu, Z; Knight, Z; Korn, WM; Kuo, WL; McCormick, F; Mills, GB; Mirzoeva, OK; Neve, RM; Parvin, B; Shokat, KM; Siwak, D; Spellman, PT; Wang, NJ; Wyrobek, AJ | 1 |
| Antonelli, A; Berti, P; Bocci, G; Canu, B; Cosconati, S; Da Settimo, F; Danesi, R; Di Desidero, T; Fioravanti, A; Frati, R; La Motta, C; Miccoli, P; Mugnaini, L; Orlandi, P; Sartini, S | 1 |
| Fujibuchi, W; Miura, K; Unno, M | 1 |
| Erbaykent-Tepedelen, B; Gonen-Korkmaz, C; Karamil, S; Korkmaz, KS | 1 |
| Fiala, C; Haider, S; Knöfler, M; Meinhardt, G; Otti, GR; Pollheimer, J; Saleh, L; Velicky, P | 1 |
| Carriquiriborde, M; Gentil, F; Gentili, C; Gigola, G; Martín, MJ; Zwenger, A | 1 |
2 review(s) available for camptothecin and cyclin d1
| Article | Year |
|---|---|
[Predictive factors of response to anti-EGFR treatments in colorectal cancer].
Topics: Amphiregulin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Camptothecin; Cetuximab; Colorectal Neoplasms; Cyclin D1; Drug Eruptions; Drug Resistance, Neoplasm; EGF Family of Proteins; Epidermal Growth Factor; Epiregulin; ErbB Receptors; Gene Dosage; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Irinotecan; Mutation; Neoplasm Proteins; Panitumumab; Polymorphism, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Receptors, IgG; Vascular Endothelial Growth Factor A | 2008 |
Splice isoforms as therapeutic targets for colorectal cancer.
Topics: Alternative Splicing; Camptothecin; Colorectal Neoplasms; Cyclin D1; Dihydrouracil Dehydrogenase (NADP); Glucuronosyltransferase; Humans; Inhibitor of Apoptosis Proteins; Irinotecan; Pregnane X Receptor; Protein Isoforms; Receptors, Steroid; Survivin; Vascular Endothelial Growth Factor A | 2012 |
10 other study(ies) available for camptothecin and cyclin d1
| Article | Year |
|---|---|
p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis.
Topics: Animals; Camptothecin; Cell Line; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; G1 Phase; Humans; Mice; Oncogene Proteins; Protein Kinase Inhibitors; Transcription, Genetic; Tumor Suppressor Protein p53 | 1995 |
Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; CDC2-CDC28 Kinases; Cell Cycle; Cells, Cultured; Cerebral Cortex; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; Cytarabine; DNA Damage; Enzyme Activation; Gene Expression Regulation, Viral; Neurons; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Sindbis Virus; Superior Cervical Ganglion; Ultraviolet Rays | 1998 |
Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.
Topics: Animals; Camptothecin; Carrier Proteins; Cell Cycle Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; DNA Damage; DNA-Binding Proteins; E2F Transcription Factors; Enzyme Inhibitors; Humans; Mice; Neurons; Nuclear Proteins; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Retinoblastoma-Like Protein p107; Transcription Factor DP1; Transcription Factors | 2000 |
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Camptothecin; Cell Division; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytoskeletal Proteins; Dinoprostone; Drug Synergism; Endothelial Growth Factors; Fluorouracil; Intercellular Signaling Peptides and Proteins; Interleukin-10; Interleukin-12; Irinotecan; Isoenzymes; Lactones; Liver Neoplasms, Experimental; Lymphokines; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Prostaglandin-Endoperoxide Synthases; Sulfones; Trans-Activators; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
[The biological point of view on pharmacogenetics of anticancer agents in colorectal cancer].
Topics: Antineoplastic Agents; Camptothecin; Colorectal Neoplasms; Cyclin D1; Dihydrouracil Dehydrogenase (NADP); Epidermal Growth Factor; Fluorouracil; Glucuronosyltransferase; Glutathione Transferase; Humans; Irinotecan; Mutation; Organoplatinum Compounds; Polymorphism, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Receptors, IgG; Thymidylate Synthase | 2008 |
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.
Topics: Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cyclin D1; Drug Synergism; ErbB Receptors; Feedback, Physiological; G1 Phase; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors | 2009 |
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cyclin D1; Drug Therapy, Combination; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Irinotecan; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines | 2011 |
DNA damage response (DDR) via NKX3.1 expression in prostate cells.
Topics: Acid Anhydride Hydrolases; Ataxia Telangiectasia Mutated Proteins; Camptothecin; Cell Cycle; Cell Line, Tumor; Cyclin D1; DNA Damage; DNA Repair; DNA Repair Enzymes; DNA-Activated Protein Kinase; DNA-Binding Proteins; Doxorubicin; Etoposide; Histones; Homeodomain Proteins; Humans; Hydrogen Peroxide; Irinotecan; Male; Metribolone; Mutagens; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Testosterone Congeners; Transcription Factors | 2014 |
Wingless ligand 5a is a critical regulator of placental growth and survival.
Topics: Apoptosis; Camptothecin; Cell Differentiation; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Female; Humans; Keratin-18; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Phosphorylation; Placenta; Placentation; Pregnancy; RNA Interference; RNA, Small Interfering; Trophoblasts; Wnt-5a Protein | 2016 |
Potential therapeutic targets for growth arrest of colorectal cancer cells exposed to PTHrP.
Topics: Animals; Apoptosis; Caco-2 Cells; Camptothecin; Carcinogenesis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclin D1; Drug Resistance, Neoplasm; HCT116 Cells; Humans; MAP Kinase Signaling System; Mice, Nude; Models, Biological; Molecular Targeted Therapy; Parathyroid Hormone-Related Protein; Phosphorylation; Protein Kinase C-alpha; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Signal Transduction; src-Family Kinases; Xenograft Model Antitumor Assays | 2018 |